{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:03:13Z","timestamp":1791489793405,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.physbeh.2015.10.031","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T13:00:19Z","timestamp":1446901219000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea"],"prefix":"10.1016","volume":"153","author":[{"given":"Bart C.","family":"De Jonghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby A.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana R.","family":"Olivos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2015.10.031_bb0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00280-010-1339-4","article-title":"Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT(3) receptor antagonists","volume":"67","author":"Percie du Sert","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.autneu.2006.01.008","article-title":"Signals for nausea and emesis: implications for models of upper gastrointestinal diseases","volume":"125","author":"Andrews","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0015","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","article-title":"Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings","volume":"15","author":"Cohen","year":"2007","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0025","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0030","doi-asserted-by":"crossref","first-page":"R341","DOI":"10.1152\/ajpregu.00413.2013","article-title":"Delineation of vagal emetic pathways: intragastric copper sulfate-induced emesis and viral tract tracing in musk shrews","volume":"306","author":"Horn","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0035","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00221-014-3985-y","article-title":"Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling","volume":"232","author":"Horn","year":"2014","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0040","first-page":"1","article-title":"Stress exposure, food intake and emotional state","author":"Ulrich-Lai","year":"2015","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0045","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1523\/JNEUROSCI.3464-14.2015","article-title":"Negative energy balance blocks neural and behavioral responses to acute stress by \u201csilencing\u201d central glucagon-like peptide 1 signaling in rats","volume":"35","author":"Maniscalco","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0060","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.physbeh.2010.02.029","article-title":"Role of the glucagon-like-peptide-1 receptor in the control of energy balance","volume":"100","author":"Hayes","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1463-1326.2006.00602.x","article-title":"Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82weeks in 314 overweight patients with type 2 diabetes","volume":"8","author":"Blonde","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2042018815580257","article-title":"Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance","volume":"6","author":"Tella","year":"2015","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0090","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0095","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect","volume":"124","author":"Sisley","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0100","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0105","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2014.03.016","article-title":"The differential antiemetic properties of GLP-1 receptor antagonist, exendin (9-39) in Suncus murinus (house musk shrew)","volume":"83","author":"Chan","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2004-0419","article-title":"The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice","volume":"146","author":"Lachey","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0120","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2174\/13816128113199990568","article-title":"The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting","volume":"20","author":"Horn","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0125","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1210\/en.2008-1479","article-title":"Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling","volume":"150","author":"Hayes","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0135","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/en.2008-1319","article-title":"Dorsal hindbrain 5\u2032-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance","volume":"150","author":"Hayes","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.6264602","article-title":"Glucoreceptors controlling feeding and blood glucose: location in the hindbrain","volume":"213","author":"Ritter","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0145","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.physbeh.2014.02.038","article-title":"Cisplatin induces neuronal activation and increases central AMPA and NMDA receptor subunit gene expression in mice","volume":"136","author":"Holland","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0160","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/annonc\/mdv138","article-title":"Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review","volume":"26","author":"Jordan","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.\/ESMO."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tem.2012.11.008","article-title":"Glucagon-like peptide 1 and appetite","volume":"24","author":"Dailey","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0175","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","article-title":"The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness","volume":"22","author":"Kinzig","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0180","first-page":"R726","article-title":"Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats","volume":"272","author":"Thiele","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2013.01.013","article-title":"Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew)","volume":"70","author":"Chan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(10)60590-9","article-title":"Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial","volume":"376","author":"Bergenstal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0195","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0200","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0205","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea","volume":"28","author":"Kendall","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2337\/diaspect.20.1.59","article-title":"Expanded use of exenatide in the management of type 2 diabetes","volume":"20","author":"John","year":"2007","journal-title":"Diab. Spectr."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0220","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","author":"Mietlicki-Baase","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0230","doi-asserted-by":"crossref","first-page":"R902","DOI":"10.1152\/ajpregu.90952.2008","article-title":"Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus)","volume":"296","author":"De Jonghe","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0235","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1523\/JNEUROSCI.0440-15.2015","article-title":"Glutamate receptors in the central nucleus of the amygdala mediate cisplatin-induced malaise and energy balance dysregulation through direct hindbrain projections","volume":"35","author":"Alhadeff","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0240","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1523\/JNEUROSCI.0440-15.2015","article-title":"Glutamate receptors in the central nucleus of the amygdala mediate cisplatin-induced malaise and energy balance dysregulation through direct hindbrain projections","volume":"35","author":"Alhadeff","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.10.031_bb0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/gast.2002.34245","article-title":"Expression of 5-HT3 receptors in the rat gastrointestinal tract","volume":"123","author":"Glatzle","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0250","article-title":"Gastric distension enhances CCK-induced c-Fos expression in the dorsal hindbrain by activating 5-HT3 receptors (abstract)","author":"Hayes","year":"2006","journal-title":"Appetite"},{"key":"10.1016\/j.physbeh.2015.10.031_bb0255","doi-asserted-by":"crossref","first-page":"G228","DOI":"10.1152\/ajpgi.00373.2003","article-title":"Gastric distension-induced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats","volume":"287","author":"Mazda","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415301608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415301608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T06:09:19Z","timestamp":1567318159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938415301608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":51,"alternative-id":["S0031938415301608"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.10.031","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}